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Corrigendum
Wang XJ, Wong SH, Givergis R, Chynn EW. Evaluation of 
analgesic efficacy of bromfenac sodium ophthalmic solution 
0.09% versus ketorolac tromethamine ophthalmic solution 
0.5% following LASEK or Epi-LASIK. Clin Ophthalmol. 
2011;5:1451–1457.
On page 1456 the Acknowledgment section details were 
incomplete. The corrected Acknowledgment section is:
ISTA Pharmaceuticals Inc provided ketorolac tromethamine 
ophthalmic solution 0.5% and bromfenac sodium ophthalmic 
solution 0.09% free of charge for this study and monetary 
compensation to the subjects to encourage participation. Dalton 
and Associates provided medical editing expertise.